Clinical Trials Directory

Trials / Completed

CompletedNCT02461953

Combination of Hemodialysis With Hemoperfusion:A Clinical Study

HA130 Hemoperfusion Apparatus Combined Hemodialysis to Improve Quality of Life in Patients Undergoing Maintenance Hemodialysis:A Perspective, Randomized, Controlled Multicenter Clinical Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
440 (actual)
Sponsor
Chinese PLA General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is a prospective, randomized, controlled multicenter clinical study. The aim of the study is to investigate whether the combination of maintenance hemodialysis (MHD) with hemoperfusion (HP) could improve the clearance rate of middle and large molecule uremic toxins so as to improve the quality of life of MHD patients and reduce their mortality rate.

Conditions

Interventions

TypeNameDescription
DEVICEhemoperfusion apparatus
DEVICElow flux dialyzer
DEVICEhigh flux dialyzer

Timeline

Start date
2015-06-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2015-06-03
Last updated
2018-06-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02461953. Inclusion in this directory is not an endorsement.

Combination of Hemodialysis With Hemoperfusion:A Clinical Study (NCT02461953) · Clinical Trials Directory